ACTIVE

Clinigen Clinical Supplies Management

Export PDF

Financial year 2025 · Closed on 30/06/2025

Net result878,8 k €-73,6 %over 1 year

Revenue56,8 M €+30,8 %over 1 year

Equity18,9 M €+24,5 %over 1 year

Workforce119,0 ETP-16,0 %over 1 year

Identity

Source · BCE/KBO

Clinigen Clinical Supplies Management is a Public limited company incorporated in 2003. Its registered office is in Mont-Saint-Guibert. It employs on average 119,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0859.906.087
Incorporation: 01/08/2003
Legal form: Public limited company
Registered office: Rue Granbonpré 11
1435 Mont-Saint-Guibert · WallonieSee on map
Contributed capital: 508 840,00 €
Latest accounts: 30/06/2025
Average workforce: 119,0 ETP

Joint committees (2)

Contacts

3 public details availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 23 filings

Trend over 18 financial years

	2025		2023		2022		2020		2019
Income statement
Revenue	56,8 M €	+30.8%	43,4 M €	-41.8%	74,6 M €	+90.7%	39,1 M €	-12.3%	44,6 M €
EBITDA	2,6 M €	-60.6%	6,7 M €	+9.8%	6,1 M €	+91.3%	3,2 M €	-53.8%	6,9 M €
Operating result	197,1 k €	-95.7%	4,5 M €	+4.9%	4,3 M €	+80.2%	2,4 M €	-59.9%	6 M €
Net result	878,8 k €	-73.6%	3,3 M €	+7.8%	3,1 M €	+100.0%	1,5 M €	-56.3%	3,5 M €
Balance sheet
Equity	18,9 M €	+24.5%	15,2 M €	+28.0%	11,9 M €	+63.2%	7,3 M €	+26.9%	5,7 M €
Total assets	44,9 M €	+75.1%	25,6 M €	-18.5%	31,4 M €	+67.6%	18,8 M €	+23.0%	15,2 M €
Cash	3,7 M €	+223%	1,2 M €	-83.7%	7,1 M €	+120%	3,2 M €	+9683%	33 k €
Debts	26 M €	+150%	10,4 M €	-46.9%	19,6 M €	+73.5%	11,3 M €	+18.7%	9,5 M €
Other
Workforce	119,0 ETP	-16.0%	141,6 ETP	+1.1%	140,1 ETP	+7.4%	130,5 ETP	+15.2%	113,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€

See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

4 active · 31 ended

Active mandates

Veronique Beautrix

Director · since 27 décembre 2024 · until 27 décembre 2030

Active

Gunter Van Hoof

Director · since 08 mai 2023 · until 01 juillet 2025

Active

Isabelle Bertaggia

Director · since 08 mai 2023 · until 12 janvier 2026

Active

Richard Paling

Director · since 11 décembre 2020 · until 09 novembre 2026

Active

Ended mandates

Richard Paling

Director · since 28 octobre 2019 · until 12 novembre 2024

Ended

Ruediger WEBER

Managing director · since 07 février 2019 · until 12 novembre 2024

Ended

PHILIPPE VANDERHOFSTADT

Managing director · since 09 janvier 2017 · until 09 mai 2022

Ended

Scott Houlton

Managing director · since 09 janvier 2017 · until 28 octobre 2019

Ended

Other companies at this address

Rue Granbonpré 11 1435 Mont-Saint-Guibert

Company	CBE no.
Ascend Performance Materials● Active	0810.113.316
Ascend Performance Materials Belgium Holdco● Active	1012.379.397
AUDANE INVEST● Active	0816.921.429
BiocSol● Active	1003.683.546
CEDRIC CLAERHOUDT● Active	0477.799.927
Cellaïon● Liquidation	0764.522.425
Cronos Sud● Active	1014.190.824
DE SMET AGRO● Active	0402.951.757
DE SMET S.A. - ENGINEERS & CONTRACTORS● Active	0438.987.752
FLEXSO BRUSSELS● Active	0898.889.892
Keiro● Active	0681.490.821
NOVADIP BIOSCIENCES● Active	0535.575.602
PARLYM BELGIUM● Active	1028.144.372
PARSMET MANAGEMENT● Active	1025.167.858
PROMETHERA BIOSCIENCES● Bankrupt	0809.788.365
TFP IMMO● Active	1032.940.330
The Akkermansia Company● Active	0664.529.083
THE TORREFACTORY PROJECT● Active	0679.686.720
Tools4Patient● Active	0534.842.954
VAT Group Ascend● Active	1002.911.308

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	10/02/2026	03/02/2025	20/11/2023	08/12/2022	07/12/2021	10/11/2020
General meeting	26/12/2025	27/12/2024	13/11/2023	14/11/2022	08/11/2021	09/11/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 23 filings

Model	Closing	General meeting	Filed	Language	Document
Full modelCorrection	30/06/2025	26/12/2025	10/02/2026	French	PDF
Full model	30/06/2025	26/12/2025	29/01/2026	French	PDF
Full model	30/06/2024	27/12/2024	03/02/2025	French	PDF
Full model	30/06/2023	13/11/2023	20/11/2023	French	PDF
Full model	30/06/2022	14/11/2022	08/12/2022	French	PDF
Full model	30/06/2021	08/11/2021	07/12/2021	French	PDF
Full model	30/06/2020	09/11/2020	10/11/2020	French	PDF
Full model	30/06/2019	09/12/2019	30/12/2019	French	PDF
Full model	31/12/2017	04/06/2018	13/06/2018	French	PDF
Full model	31/12/2016	29/05/2017	29/05/2017	French	PDF
Full model	31/12/2015	09/05/2016	20/06/2016	French	PDF
Abridged model	31/12/2014	11/05/2015	19/05/2015	French	PDF
Abridged model	31/12/2013	12/05/2014	13/05/2014	French	PDF
Abridged model	31/12/2012	13/05/2013	06/06/2013	French	PDF
Abridged model	31/12/2011	14/05/2012	21/05/2012	French	PDF
Abridged model	31/12/2010	09/05/2011	10/05/2011	French	PDF
Abridged model	31/12/2009	31/05/2010	29/06/2010	French	PDF
Abridged model	31/12/2008	05/06/2009	16/06/2009	French	PDF
Abridged modelCorrection	31/12/2007	13/05/2008	05/05/2009	French	PDF
Abridged model	31/12/2007	13/05/2008	25/06/2008	French	PDF
Abridged modelCorrection	31/12/2006	29/05/2007	05/05/2009	French	PDF
Abridged model	31/12/2006	29/05/2007	22/06/2007	French	PDF
Abridged modelCorrection	31/12/2005	08/05/2006	05/05/2009	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

4 active · 31 ended

Active mandates

Veronique Beautrix

Director · since 27 décembre 2024 · until 27 décembre 2030

Active

Gunter Van Hoof

Director · since 08 mai 2023 · until 01 juillet 2025

Active

Isabelle Bertaggia

Director · since 08 mai 2023 · until 12 janvier 2026

Active

Richard Paling

Director · since 11 décembre 2020 · until 09 novembre 2026

Active

Ended mandates

Richard Paling

Director · since 28 octobre 2019 · until 12 novembre 2024

Ended

Ruediger WEBER

Managing director · since 07 février 2019 · until 12 novembre 2024

Ended

PHILIPPE VANDERHOFSTADT

Managing director · since 09 janvier 2017 · until 09 mai 2022

Ended

Scott Houlton

Managing director · since 09 janvier 2017 · until 28 octobre 2019

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Restructuring21/05/2026
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Restructuring09/03/2026
CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Restructuring29/12/2025
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - DIVERS
PDF
Mandates17/10/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates14/03/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates14/03/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates23/08/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates19/05/2023
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025878,8 k €↓
2023
Annual accounts 20233,3 M €↑
2022
Annual accounts 20223,1 M €↑
2020
Annual accounts 20201,5 M €↓
2019
Annual accounts 20193,5 M €↑
2017
Annual accounts 20171,2 M €↑
2016
Annual accounts 2016839 k €↑
2015
Annual accounts 2015-309,5 k €↓
2014
Annual accounts 2014568,5 k €↑
2013
Annual accounts 2013317,3 k €↑
2012
Annual accounts 201213,9 k €↑
2011
Annual accounts 201113,8 k €↑
2010
Annual accounts 2010-206,6 k €↓
2009
Annual accounts 200914,3 k €↓
2008
Annual accounts 200874,1 k €↓
2007
Annual accounts 2007349,2 k €↑
2006
Annual accounts 200611,5 k €↑
2005
Annual accounts 2005-216,5 k €
01/08/2003
IncorporationPublic limited company

Clinigen Clinical Supplies Management

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline